Who is the CEO of Patel Chem Specialities Ltd?
- Answer Field
-
The CEO or Managing Director of Patel Chem Specialities Ltd is Mr. Bhupesh V Patel.
BAJAJ BROKING
Patel Chem Specialities Limited (PCSL), incorporated in 2008, is involved in the production and export of pharmaceutical excipients and specialty chemicals. The company’s product line includes widely used compounds such as binders, disintegrants, thickeners, stabilisers, and gelling agents that support multiple industries including pharmaceuticals, food, cosmetics, and industrial applications. With manufacturing facilities located in Vatva, Ahmedabad, and Talod, Himmatnagar, the company adheres to recognised quality certifications like US-DMF and GMP, enabling large-scale production.
The facility spans 7,000 square yards and holds an annual production capacity of more than 7,200 MT. The setup is supported by departments such as production, R&D, quality control, packaging, and warehousing. PCSL has built a presence in global markets such as East Asia, Europe, the Middle East, North America, and Southeast Asia. Its product portfolio includes Rheollose®, Disolwell®, Swellcal®, and AmyloTab™, catering to a wide range of functional needs.
For more details, visit the Patel Chem Specialities IPO page.
Details | Information |
IPO Date | July 25, 2025 to July 29, 2025 |
Issue Size | 70,00,000 shares (aggregating up to ₹58.80 Cr) |
Price Band | ₹82 to ₹84 per share |
Lot Size | 1600 shares |
Listing At | BSE SME |
Market maker | Globalworth Securities Limited |
Funding capital expenditure to set up plant at Indrad, Mahesana for manufacturing Croscarmellose Sodium (“CCS”), Sodium Starch Glycolate (“SSG”) – Corn Starch Base & Potato Starch Base and Calcium Carboxymethylcellulose (CMC)
General Corporate Purposes
Event | Date |
---|---|
IPO Open Date | Fri, Jul 25, 2025 |
IPO Close Date | Tue, Jul 29, 2025 |
Tentative Allotment | Wed, Jul 30, 2025 |
Initiation of Refunds | Thu, Jul 31, 2025 |
Credit of Shares to Demat | Thu, Jul 31, 2025 |
Tentative Listing Date | Fri, Aug 1, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2025 |
₹82 to ₹84 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 3,200 | ₹2,68,800 |
Individual investors (Retail) (Max) | 2 | 3,200 | ₹2,68,800 |
S-HNI (Min) | 3 | 4,800 | ₹4,03,200 |
S-HNI (Max) | 7 | 11,200 | ₹9,40,800 |
B-HNI (Min) | 8 | 12,800 | ₹10,75,200 |
Log in to Your Trading Account Access your trading account through your broker’s platform.
Navigate to the IPO Section Go to the IPO section to view active IPO listings.
Select Patel Chem Specialities IPO Find "Patel Chem Specialities IPO" and click on the ‘Apply’ button.
Enter Application Details Specify the number of lots (minimum lot size: 1600 shares) and the bid price within the range of ₹82 to ₹84 per share.
Provide Your UPI ID Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on July 29, 2025, to complete your application process.
Total Assets: Grew from ₹37.08 crore in FY23 to ₹65.31 crore as of March 2025.
Revenue: Reached ₹105.55 crore in FY25.
Profit After Tax (PAT): Stood at ₹10.57 crore for March 2025.
Net Worth: Recorded at ₹35.40 crore in FY25.
Reserves and Surplus: Recorded at ₹17.53 crore (March 2025), growing steadily over the years.
EBITDA: Stood at ₹15.80 crore in March 2025.
The company has reported a steady increase in its total assets over the past financial years, indicating an expansion in operational scale.
Revenue generation has shown consistent progress, reflecting growing demand for its products in both domestic and international markets.
Profitability has remained stable, suggesting effective cost management and operational efficiency.
The net worth of the company has seen a healthy rise, supporting its financial position and business sustainability.
Reserves and surplus have grown over time, contributing to the company's internal strength and capacity for reinvestment.
Operational earnings have maintained a positive trend, reinforcing the company's ability to generate income from its core business activities.
The company operates in a highly specialised chemical segment, which may be sensitive to regulatory changes, supply chain disruptions, or fluctuations in raw material availability.
Expansion into new production facilities, such as the upcoming Indrad plant, may involve execution-related challenges and uncertainties associated with capacity scaling and market demand.
The IPO proceeds are aimed at funding capital expenditure for new product lines, indicating a potential increase in production capacity and market reach.
With an established presence across global markets and a growing product portfolio, the company is positioned to tap into rising demand for pharmaceutical excipients and specialty chemicals across multiple sectors.
KPI | Values |
ROE | 29.85% |
ROCE | 36.26% |
Debt/Equity | 0.42 |
RoNW | 24.32% |
PAT Margin | 10.01% |
EBITDA Margin | 14.97% |
Price to Book Value | 4.11 |
Registrar | Lead Manager(s) |
---|---|
MUFG Intime India Private Limited (Link Intime) | Cumulative Capital Private Limited |
Patel Chem Specialities Ltd.
Plot No. 272/4-5,
Phase II, G.I.D.C Industrial Estate,
Vatva Road
Ahmedabad, Gujarat, 382445
Phone: 91- 9712999854
Email: cs@patelchem.com
Website: http://www.patelchem.com/
Patel Chem Specialities Limited operates in the field of pharmaceutical excipients and specialty chemicals, with a focus on manufacturing compounds that serve various industries. The company’s production units in Gujarat and its presence in global markets contribute to its operational spread. The product portfolio includes functional ingredients used in pharmaceuticals, food, cosmetics, and industrial applications.
The upcoming IPO is aimed at supporting capital expenditure for a new manufacturing facility and meeting general corporate needs. With defined financial performance and a targeted expansion plan, the offering outlines both operational developments and sector-focused initiatives.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Patel Chem Specialities IPO.
Share this article:
No result found
The CEO or Managing Director of Patel Chem Specialities Ltd is Mr. Bhupesh V Patel.
The IPO will open for subscription on July 25, 2025, and will close on July 29, 2025.
Patel Chem Specialities Ltd is engaged in the manufacturing and export of pharmaceutical excipients and specialty chemicals. These are widely used across pharmaceutical, food, cosmetic, and industrial applications. The company operates in a sector that supplies essential inputs to multiple industries. Its business model is built around production scale, international certifications, and a diversified product range, which may contribute to operational continuity if market conditions remain stable.
The issue size is 70,00,000 shares, aggregating up to ₹58.80 crore.
'Pre-apply' allows investors to place their IPO bids before the subscription window officially opens. These bids are recorded and submitted to the exchange as soon as the IPO opens.
Once your UPI mandate is approved and the application is successfully submitted, you will receive a confirmation from your broker or platform indicating that your IPO order has been placed.
The lot size is 1,600 shares. The minimum order quantity for retail investors is 2 lots, i.e., 3,200 shares.
The tentative allotment date is July 30, 2025.
The registrar for this IPO is MUFG Intime India Private Limited (Link Intime).
As per available public disclosures, there are no reported governance issues or board-related red flags associated with Patel Chem Specialities Ltd. Investors may refer to the Draft Red Herring Prospectus (DRHP) or RHP for detailed board composition and disclosures.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading